日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The HKDC1-ASS1-ACSBG2 axis reprograms lipid metabolism to drive therapeutic resistance in hepatocellular carcinoma

HKDC1-ASS1-ACSBG2轴重编程脂质代谢,从而驱动肝细胞癌的治疗耐药性。

Ling, Xiangyu; Zhao, Wenhu; Li, Kuan; Liang, Litao; Jia, Wenbo; Wang, Jinyi; Feng, Yanzhi; Xu, Chao; Lv, Qingpeng; Feng, Zhiwen; Zhu, Deming; Kong, Lianbao; Ding, Wenzhou

TTC36-Mediated Tumor Suppression via YBX3/SPRED1 Axis Paradoxically Reduces Sorafenib Sensitivity in Hepatocellular Carcinoma

TTC36通过YBX3/SPRED1轴介导的肿瘤抑制作用反而降低了肝细胞癌对索拉非尼的敏感性

Zhao, Wenhu; Ling, Xiangyu; Li, Kuan; Liang, Litao; Jia, Wenbo; Wang, Jinyi; Feng, Yanzhi; Xu, Chao; Lv, Qingpeng; Zhu, Deming; Feng, Zhiwen; Ai, Xiaoming; Kong, Lianbao; Ding, Wenzhou

Predicting hepatocellular carcinoma outcomes and immune therapy response with ATP-dependent chromatin remodeling-related genes, highlighting MORF4L1 as a promising target

利用ATP依赖性染色质重塑相关基因预测肝细胞癌预后和免疫治疗反应,重点关注MORF4L1这一有前景的靶点

Xu, Chao; Liang, Litao; Liu, Guoqing; Feng, Yanzhi; Xu, Bin; Zhu, Deming; Jia, Wenbo; Wang, Jinyi; Zhao, Wenhu; Ling, Xiangyu; Zhou, Yongping; Ding, Wenzhou; Kong, Lianbao

GALNT7 promotes hepatocellular carcinoma progression by activating the PI3K/AKT signaling pathway via O-glycosylation of MUC13

GALNT7通过对MUC13进行O-糖基化,激活PI3K/AKT信号通路,从而促进肝细胞癌的进展。

Liang, Litao; Xu, Chao; Wang, Yunfeng; Feng, Yanzhi; Jia, Wenbo; Wang, Jinyi; Zhao, Wenhu; Ling, Xiangyu; Ding, Wenzhou; Han, Bing; Ai, Xiaoming; Kong, Lianbao; Zhou, Yongping

Liver X Receptor Activation Alleviates Hepatic Ischemia-Reperfusion Injury in Diabetes by Inhibiting NF-κB-NLRP3 Activation.

肝X受体激活通过抑制NF-κB-NLRP3激活来减轻糖尿病肝脏缺血再灌注损伤

Jiang Chuanwei, Ding Wenzhou, Hu Yuanchang, Yang Chao

HNF4A-AS1 inhibits the progression of hepatocellular carcinoma by promoting the ubiquitin-modulated degradation of PCBP2 and suppressing the stability of ARG2 mRNA.

HNF4A-AS1 通过促进 PCBP2 的泛素调节降解和抑制 ARG2 mRNA 的稳定性来抑制肝细胞癌的进展

Jia Wenbo, Yu Liang, Xu Bin, Feng Yanzhi, Wang Jinyi, Zhu Deming, Xu Chao, Liang Litao, Zhou Yongping, Kong Lianbao, Ding Wenzhou

BAIAP2L2 promotes the malignancy of hepatocellular carcinoma via GABPB1-mediated reactive oxygen species imbalance

BAIAP2L2通过GABPB1介导的活性氧失衡促进肝细胞癌的恶性进展。

Jia, Wenbo; Xu, Bin; Yu, Liang; Feng, Yanzhi; Wang, Jinyi; Xu, Chao; Liang, Litao; Zhou, Yongping; Ding, Wenzhou; Kong, Lianbao

LINC01535 promotes hepatocellular carcinoma proliferation and metastasis by regulating the miR-214-3p/VASP axis

LINC01535通过调控miR-214-3p/VASP轴促进肝细胞癌的增殖和转移。

Liu, Chunjiang; Li, Kuan; Ding, Wenzhou; Tang, Xiaoqi; Wu, Zhifeng; Zhu, Xin; Gong, Wanwan; Zhao, Hui

Derivation and validation of machine learning models for preoperative estimation of microvascular invasion risk in hepatocellular carcinoma

构建和验证用于肝细胞癌术前微血管侵犯风险评估的机器学习模型

Chen, Zhiqiang; Zuo, Xueliang; Zhang, Yao; Han, Guoyong; Zhang, Long; Ding, Wenzhou; Wu, Jindao; Wang, Xuehao

M2 Macrophage-Derived Exosomes Facilitate HCC Metastasis by Transferring α(M) β(2) Integrin to Tumor Cells

M2巨噬细胞来源的外泌体通过将α(M)β(2)整合素转移至肿瘤细胞促进肝细胞癌转移

Wu, Jindao; Gao, Wen; Tang, Qiyun; Yu, Yue; You, Wei; Wu, Zhengshan; Fan, Ye; Zhang, Long; Wu, Chen; Han, Guoyong; Zuo, Xueliang; Zhang, Yao; Chen, Zhiqiang; Ding, Wenzhou; Li, Xiangcheng; Lin, Fengming; Shen, Hongbing; Tang, Jinhai; Zhang, Yaqin; Wang, Xuehao